The Implantable Tibial Neuromodulation (ITNM) device will expand treatment options for the 16 million people living with urinary urges and involuntary leaks GALWAY, Ireland, Sept. 19, 2025 /PRNewswire ...

Artificial urinary sphincter implantation is an effective option with an acceptable complication rate for moderate to severe stress urinary incontinence.

The Implantable Tibial Neuromodulation (ITNM) device will expand treatment options for the 16 million people living with urinary urges and involuntary leaks Bladder control problems affect an ...

The Implantable Tibial Neuromodulation (ITNM) device will expand treatment options for the 16 million people living with urinary urges and involuntary leaks GALWAY, Ireland, Sept. 19, 2025 /PRNewswire ...

New York, April 23, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Urinary Incontinence Device Market - Premium Insight ...

Credit: Watkins-Conti. Yōni.Fit is a self-administered, intravaginal insert that manages urinary incontinence without interfering with voluntary urination. The prescription device can be used during a ...

Company is Poised to Participate in $4B U.S. Adult Urinary Incontinence Market EDMOND, Okla., May 17, 2024 /PRNewswire/ -- Watkins-Conti Products, Inc. ("Watkins-Conti"), a company that develops ...

The FDA has given marketing approval to a new implant aimed at treating urinary incontinence. The device focuses on reducing barriers to treatment for patients. Experts say that this product is ...

Relief Srl raised more than €1 million (US$1.08 million) in financing for Urorelief, its endourethral medical device which treats stress urinary incontinence. The Italian startup will use the funds to ...